• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外科医生对接受乳腺癌保乳术后行对侧预防性乳房切除术的女性的影响。

Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.

机构信息

Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor.

Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor.

出版信息

JAMA Surg. 2018 Jan 1;153(1):29-36. doi: 10.1001/jamasurg.2017.3415.

DOI:10.1001/jamasurg.2017.3415
PMID:28903158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5833615/
Abstract

IMPORTANCE

Rates of contralateral prophylactic mastectomy (CPM) have markedly increased but we know little about the influence of surgeons on variability of the procedure in the community.

OBJECTIVE

To quantify the influence of the attending surgeon on rates of CPM and clinician attitudes that explained it.

DESIGN, SETTING, AND PARTICIPANTS: In this population-based survey study, we identified 7810 women with stages 0 to II breast cancer treated in 2013 to 2015 through the Surveillance, Epidemiology, and End Results registries of Georgia and Los Angeles County. Surveys were sent approximately 2 months after surgery. Surveys were also sent to 488 attending surgeons identified by the patients.

MAIN OUTCOMES AND MEASURES

We conducted multilevel analyses to examine the impact of surgeon influence on variations in patient receipt of CPM using information from patient and surgeon surveys merged to Surveillance, Epidemiology, and End Results data.

RESULTS

A total of 5080 women responded to the survey (70% response rate), and 377 surgeons responded (77% response rate). The mean (SD) age of responding women was 61.9 (11) years; 28% had an increased risk of second primary cancer, and 16% received CPM. Half of surgeons (52%) practiced for more than 20 years and 30% treated more than 50 new patients with breast cancer annually. Attending surgeon explained a large amount (20%) of the variation in CPM, controlling for patient factors. The odds of a patient receiving CPM increased almost 3-fold (odds ratio, 2.8; 95% CI, 2.1-3.4) if she saw a surgeon with a practice approach 1 SD above a surgeon with the mean CPM rate (independent of age, diagnosis date, BRCA status, and risk of second primary). One-quarter (25%) of the surgeon influence was explained by attending attitudes about initial recommendations for surgery and responses to patient requests for CPM. The estimated rate of CPM was 34% for surgeons who least favored initial breast conservation and were least reluctant to perform CPM vs 4% for surgeons who most favored initial breast conservation and were most reluctant to perform CPM.

CONCLUSIONS AND RELEVANCE

In this study, attending surgeons exerted influence on the likelihood of receipt of CPM after a breast cancer diagnosis. Variations in surgeon attitudes about recommendations for surgery and response to patient requests for CPM explain a substantial amount of this influence.

摘要

重要性

对侧预防性乳房切除术 (CPM) 的比率显著增加,但我们对社区中外科医生对该手术的变异性的影响知之甚少。

目的

量化主治外科医生对 CPM 比率的影响以及解释这种影响的临床医生态度。

设计、环境和参与者:在这项基于人群的调查研究中,我们通过佐治亚州和洛杉矶县的监测、流行病学和最终结果登记处,确定了 2013 年至 2015 年间接受治疗的 7810 名 0 期至 2 期乳腺癌女性。手术大约两个月后发出调查。还向患者确定的 488 名主治外科医生发送了调查。

主要结果和测量

我们进行了多水平分析,使用来自患者和外科医生调查的信息,结合监测、流行病学和最终结果数据,检查外科医生对患者接受 CPM 的影响。

结果

共有 5080 名女性对调查做出回应(70%的回应率),377 名外科医生做出回应(77%的回应率)。接受调查的女性的平均(SD)年龄为 61.9(11)岁;28%有第二原发癌的高风险,16%接受了 CPM。一半的外科医生(52%)从业超过 20 年,每年治疗超过 50 名新的乳腺癌患者。主治外科医生解释了很大一部分(20%)CPM 的变化,控制了患者因素。如果患者看到一位手术方法比平均 CPM 率的外科医生高出 1 个标准差的外科医生,那么接受 CPM 的可能性几乎增加了两倍(比值比,2.8;95%置信区间,2.1-3.4)(独立于年龄、诊断日期、BRCA 状态和第二原发癌的风险)。25%的外科医生影响可以通过主治医生对手术初始建议的态度以及对患者 CPM 请求的反应来解释。最不赞成初始乳房保留且最不愿意进行 CPM 的外科医生的 CPM 估计率为 34%,而最赞成初始乳房保留且最不愿意进行 CPM 的外科医生的 CPM 估计率为 4%。

结论和相关性

在这项研究中,主治外科医生对乳腺癌诊断后接受 CPM 的可能性产生了影响。外科医生对手术建议的态度以及对患者 CPM 请求的反应的变化解释了这种影响的很大一部分。

相似文献

1
Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.外科医生对接受乳腺癌保乳术后行对侧预防性乳房切除术的女性的影响。
JAMA Surg. 2018 Jan 1;153(1):29-36. doi: 10.1001/jamasurg.2017.3415.
2
Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.患者对医生关于乳腺癌治疗的对侧预防性乳房切除术建议的反应。
JAMA Surg. 2017 Jul 1;152(7):658-664. doi: 10.1001/jamasurg.2017.0458.
3
Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.早期乳腺癌患者基于人群样本的对侧预防性乳房切除术决策
JAMA Surg. 2017 Mar 1;152(3):274-282. doi: 10.1001/jamasurg.2016.4749.
4
Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.术后主刀医生与乳腺癌患者接受基因检测的差异关联。
JAMA Surg. 2018 Oct 1;153(10):909-916. doi: 10.1001/jamasurg.2018.2001.
5
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.对侧预防性乳房切除术的社会和临床决定因素
JAMA Surg. 2014 Jun;149(6):582-9. doi: 10.1001/jamasurg.2013.5689.
6
The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.在一项基于人群的乳腺癌患者样本中,患者态度和价值观与对侧预防性乳房切除术考虑强度之间的关联。
Cancer. 2017 Dec 1;123(23):4547-4555. doi: 10.1002/cncr.30924. Epub 2017 Aug 15.
7
Postmastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives.乳腺癌根治术后乳房再造:探索整形医师的实践模式和观点。
Plast Reconstr Surg. 2020 Apr;145(4):865-876. doi: 10.1097/PRS.0000000000006627.
8
Exploring Surgeon Variability in Recommendations for Contralateral Prophylactic Mastectomy: What Matters Most?探讨外科医生在推荐对侧预防性乳房切除术方面的差异:什么最重要?
Ann Surg Oncol. 2019 Oct;26(10):3224-3231. doi: 10.1245/s10434-019-07561-y. Epub 2019 Jul 24.
9
Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer.选择何处进行乳房手术重要吗?:手术医生的影响与乳腺癌乳房切除术接受率的变化。
Med Care. 2010 Oct;48(10):892-9. doi: 10.1097/MLR.0b013e3181ef97df.
10
Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy.乳腺外科医生对双侧预防性乳房切除术的看法和态度。
ANZ J Surg. 2013 Jul;83(7-8):527-32. doi: 10.1111/j.1445-2197.2012.06209.x. Epub 2012 Oct 8.

引用本文的文献

1
The relationship among body image, psychological distress, and quality of life in young breast cancer patients: a cross-sectional study.年轻乳腺癌患者的身体意象、心理困扰与生活质量之间的关系:一项横断面研究。
Front Psychol. 2024 Aug 21;15:1411647. doi: 10.3389/fpsyg.2024.1411647. eCollection 2024.
2
Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks.外科肿瘤学会乳房疾病部位工作组关于对侧乳房切除术的声明:适应证、结果和风险。
Ann Surg Oncol. 2024 Apr;31(4):2212-2223. doi: 10.1245/s10434-024-14893-x. Epub 2024 Jan 23.
3
Decision-making experiences of breast cancer patients related to contralateral prophylactic mastectomy-a systematic meta-synthesis of qualitative studies.乳腺癌患者对侧预防性乳房切除术的决策经历——定性研究的系统元综合分析
Support Care Cancer. 2023 Mar 15;31(4):214. doi: 10.1007/s00520-023-07674-x.
4
Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?简短的外科医生谈判理论原则培训是否会降低预防性对侧乳房切除术的比率?
Breast Cancer Res Treat. 2023 May;199(1):119-126. doi: 10.1007/s10549-023-06891-6. Epub 2023 Mar 7.
5
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.EBCC-13 宣言:权衡利弊,决定是否行对侧预防性乳房切除术。
Eur J Cancer. 2023 Mar;181:79-91. doi: 10.1016/j.ejca.2022.11.036. Epub 2022 Dec 13.
6
The role of tumor phenotype in the surgical treatment of early-stage breast cancer.肿瘤表型在早期乳腺癌手术治疗中的作用。
Am J Surg. 2023 Jan;225(1):84-92. doi: 10.1016/j.amjsurg.2022.09.029. Epub 2022 Sep 22.
7
Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer.探讨具有低危风险前列腺癌男性接受推荐的主动监测的差异。
J Urol. 2022 Sep;208(3):600-608. doi: 10.1097/JU.0000000000002734. Epub 2022 May 6.
8
Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.围绕着对侧预防性乳房切除术的手术决策:一项对乳腺癌患者进行的多中心调查的治疗目标、偏好和心理社会结果比较。
Ann Surg Oncol. 2021 Dec;28(13):8752-8765. doi: 10.1245/s10434-021-10426-y. Epub 2021 Jul 12.
9
Neoadjuvant Chemotherapy in Breast Cancer: Review of the Evidence and Conditions That Facilitated Its Use during the Global Pandemic.新辅助化疗在乳腺癌中的应用:全球大流行期间促进其使用的证据和条件综述。
Curr Oncol. 2021 Mar 24;28(2):1338-1347. doi: 10.3390/curroncol28020127.
10
Contralateral prophylactic mastectomy and implications for breast reconstruction.对侧预防性乳房切除术及其对乳房重建的影响。
Gland Surg. 2021 Jan;10(1):498-506. doi: 10.21037/gs.2020.03.15.

本文引用的文献

1
Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.患者对医生关于乳腺癌治疗的对侧预防性乳房切除术建议的反应。
JAMA Surg. 2017 Jul 1;152(7):658-664. doi: 10.1001/jamasurg.2017.0458.
2
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .新诊断乳腺癌患者的基因检测与咨询
JAMA. 2017 Feb 7;317(5):531-534. doi: 10.1001/jama.2016.16918.
3
Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.早期乳腺癌患者基于人群样本的对侧预防性乳房切除术决策
JAMA Surg. 2017 Mar 1;152(3):274-282. doi: 10.1001/jamasurg.2016.4749.
4
Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.外科肿瘤学会乳腺疾病工作组关于预防性(降低风险)乳房切除术的声明。
Ann Surg Oncol. 2017 Feb;24(2):375-397. doi: 10.1245/s10434-016-5688-z. Epub 2016 Dec 8.
5
Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.美国乳腺外科医师协会关于对侧预防性乳房切除术(CPM)的共识声明:CPM的结果与风险数据
Ann Surg Oncol. 2016 Oct;23(10):3100-5. doi: 10.1245/s10434-016-5443-5. Epub 2016 Jul 28.
6
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.黑色素瘤临床实践指南(2016 年版),NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2016 Apr;14(4):450-73. doi: 10.6004/jnccn.2016.0051.
7
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.遗传/家族性高风险评估:乳腺和卵巢,第 2.2015 版。
J Natl Compr Canc Netw. 2016 Feb;14(2):153-62. doi: 10.6004/jnccn.2016.0018.
8
Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.1998 年至 2011 年加利福尼亚州乳腺癌患者行双侧乳房切除术与其他手术治疗方法的应用及死亡率比较。
JAMA. 2014 Sep 3;312(9):902-14. doi: 10.1001/jama.2014.10707.
9
Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.美国行乳房切除术的乳腺癌患者乳房再造使用的趋势和变化。
J Clin Oncol. 2014 Mar 20;32(9):919-26. doi: 10.1200/JCO.2013.52.2284. Epub 2014 Feb 18.
10
Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.临床管理因素影响对侧预防性乳房切除术的决策。
J Clin Oncol. 2011 Jun 1;29(16):2158-64. doi: 10.1200/JCO.2010.29.4041. Epub 2011 Apr 4.